Axe Compute Inc. logo

Axe Compute Inc.

AGPU

NASDAQTechnologySoftware - Infrastructure

Previous close

$10.21

−$0.48 · -4.49%

Aug 21, 4:00 PM ET

AGPU company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

2

Overpriced

Momentum

54

Neutral

Sentiment

58

Mixed

Risk resilience

12

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Headquartered in Pittsburgh, Pennsylvania, Axe Compute Inc., established in 2002 and formerly known as Predictive Oncology Inc. until its December 2025 renaming, is an enterprise that leverages profound scientific insights and artificial intelligence (AI) to advance the discovery and development of cancer treatments. The company's operations are divided into two distinct segments. Its Pittsburgh division offers AI-driven services, utilizing an exclusive biobank containing over 150,000 tumor samples, and engineers specialized 3D cell culture models vital for drug advancement. Meanwhile, the Eagan division produces the FDA-approved STREAMWAY System and related products, which facilitate automated medical fluid waste management and direct patient-to-drain fluid disposal. Additionally, Axe Compute maintains a strategic partnership with Every Cure to identify and prioritize existing pharmaceuticals for repurposing.

Industry
Software - Infrastructure
Sector
Technology
Headquarters
US
CEO
Christopher Miglino
Listed since
May 3, 2010
Employees
14

Market position

Day range

Current $10.21

52-week range

Current $10.21

Open
$10.69
Previous close
$10.69
Volume
529.49K
1.23× average
Average volume
430.91K
Average daily volume
Market cap
117.36M USD
Beta
3.47
Market reference 1
50-day average
$7.8468
+30.12% above average
200-day average
$5.5872
+82.74% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
115.5M USD
P/E (TTM)
-0.07×
P/B (TTM)
5.9×
P/S (TTM)
35.97×
EV / EBITDA
-0.5×
Earnings yield
-187.04%
Free cash flow yield
-34.10%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
1.65%
Operating margin
-953.64%
Net margin
-7769.79%
Return on equity
-488.50%
Return on assets
-440.73%
Return on invested capital
-57.56%

Financial health

Debt / equity
0.05×
Current ratio
10.02×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends18678%-55770%-130217%-204665%Gross margin, FY2021: 65.72%Gross margin, FY2022: 66.45%Gross margin, FY2023: 62.57%Gross margin, FY2024: 49.12%Gross margin, FY2025: 42.03%Operating margin, FY2021: -1437.95%Operating margin, FY2022: -1729.28%Operating margin, FY2023: -744.47%Operating margin, FY2024: -673.69%Operating margin, FY2025: -22688.58%Net margin, FY2021: -1383.65%Net margin, FY2022: -1709.62%Net margin, FY2023: -859.13%Net margin, FY2024: -751.39%Net margin, FY2025: -186053.45%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 65.72%. Gross margin FY2022 66.45%. Gross margin FY2023 62.57%. Gross margin FY2024 49.12%. Gross margin FY2025 42.03%. Operating margin FY2021 -1437.95%. Operating margin FY2022 -1729.28%. Operating margin FY2023 -744.47%. Operating margin FY2024 -673.69%. Operating margin FY2025 -22688.58%. Net margin FY2021 -1383.65%. Net margin FY2022 -1709.62%. Net margin FY2023 -859.13%. Net margin FY2024 -751.39%. Net margin FY2025 -186053.45%.

Income trends

Revenue

125.28K USD-92.28%

Operating income

−28.43M USD-159.84%

Net income

−233.1M USD-1810.42%
Income trends across reported periods25.1M USD−68.79M USD−162.68M USD−256.57M USDRevenue, FY2021: 1.42M USDRevenue, FY2022: 1.51M USDRevenue, FY2023: 1.63M USDRevenue, FY2024: 1.62M USDRevenue, FY2025: 125.28K USDOperating income, FY2021: −20.43M USDOperating income, FY2022: −26.03M USDOperating income, FY2023: −12.12M USDOperating income, FY2024: −10.94M USDOperating income, FY2025: −28.43M USDNet income, FY2021: −19.66M USDNet income, FY2022: −25.74M USDNet income, FY2023: −13.98M USDNet income, FY2024: −12.2M USDNet income, FY2025: −233.1M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.42M USD. Revenue FY2022 1.51M USD. Revenue FY2023 1.63M USD. Revenue FY2024 1.62M USD. Revenue FY2025 125.28K USD. Operating income FY2021 −20.43M USD. Operating income FY2022 −26.03M USD. Operating income FY2023 −12.12M USD. Operating income FY2024 −10.94M USD. Operating income FY2025 −28.43M USD. Net income FY2021 −19.66M USD. Net income FY2022 −25.74M USD. Net income FY2023 −13.98M USD. Net income FY2024 −12.2M USD. Net income FY2025 −233.1M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue125.28K USD1.62M USD1.63M USD1.51M USD1.42M USD
Cost of goods sold72.62K USD826.14K USD609.21K USD505.11K USD487.02K USD
Gross profit52.66K USD797.68K USD1.02M USD1M USD933.66K USD
Research and development2.15M USD25.99K USD122.31K USD320.32K USD315.85K USD
Selling, general, and administrative26.33M USD8.89M USD9.06M USD12.47M USD11.71M USD
Operating expenses28.48M USD11.74M USD13.14M USD27.03M USD21.36M USD
Interest expense10.65M USD
Depreciation and amortization688.58K USD695.66K USD244.79K USD1.31M USD1.34M USD
Operating income−28.43M USD−10.94M USD−12.12M USD−26.03M USD−20.43M USD
Net income−233.1M USD−12.2M USD−13.98M USD−25.74M USD−19.66M USD

Company facts updated Aug 24, 2026.

Corporate actions

Corporate action history

Stock split

Effective Sep 30, 2025

1:15

Stock split

Effective Apr 24, 2023

1:20

Stock split

Effective Oct 29, 2019

1:10

Stock split

Effective Oct 28, 2016

1:25

Stock split

Effective Oct 28, 2014

1:75

AGPU peers

ETFs holding AGPU

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research AGPU

research.disclaimer